MYCOPLASM M 250 Mycophenolate mofetil (250mg) Mycophenolate mofetil is a medication used in transplantation medicine and autoimmune diseases to suppress the immune system. It is commonly prescribed under various brand names, including CellCept. Here are some key points about mycophenolate mofetil: Immunosuppressant: Mycophenolate mofetil is classified as an immunosuppressant. It works by inhibiting the proliferation of certain white blood cells, particularly T and B lymphocytes. By reducing the activity of these immune cells, the medication helps prevent the rejection of transplanted organs and can also be used to manage autoimmune conditions. Indications: Transplantation: Mycophenolate mofetil is often used in combination with other immunosuppressive drugs to prevent organ rejection in transplant recipients. It is used for kidney, heart, and liver transplants, among others. Autoimmune Diseases: Mycophenolate mofetil is sometimes prescribed for autoimmune conditions such as lupus nephritis, rheumatoid arthritis, and inflammatory bowel disease. Dosage: The dosage of mycophenolate mofetil varies depending on the specific transplant type or autoimmune disease being treated, as well as individual patient factors. It is usually taken as an oral tablet or suspension. Your healthcare provider will determine the appropriate dose and treatment plan. Monitoring: While on mycophenolate mofetil, patients often undergo regular monitoring of blood counts, kidney function, and liver function to assess the medication's safety and efficacy. Dose adjustments may be made based on these tests. Side Effects: Common side effects of mycophenolate mofetil may include gastrointestinal symptoms such as nausea, vomiting, diarrhea, and abdominal pain. It can also increase the risk of infections and may have other side effects. Serious adverse effects are possible, and it is crucial to report any unusual symptoms to your healthcare provider. Contraception: Mycophenolate mofetil can cause severe birth defects if taken during pregnancy. Patients of childbearing potential should use reliable contraception while taking the medication and for some time after discontinuation, as directed by their healthcare provider. Consultation: Mycophenolate mofetil is a prescription medication, and its use should be closely supervised by a healthcare professional experienced in transplant medicine or autoimmune disease management. It is essential to discuss any questions or concerns about this medication with your healthcare provider, who can provide personalized guidance based on your specific medical condition and needs. This information is for general knowledge, and you should consult a healthcare professional for specific advice and guidance regarding your medical condition and treatment with mycophenolate mofetil. Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us. For further information please contact: info@sterispharma.com order now: https://www.sterisonline.com/product/mycoplasm-m-250-134214